LONDON (Reuters) – Britain has secured 5 million doses of Moderna’s experimental COVID-19 vaccine after interim data indicated it was 94.5% effective, health minister Matt Hancock said on Monday.
“We have today secured an initial agreement for 5 million doses of the Moderna vaccine,” Hancock said at a news conference.
